Meanwhile, total life sciences lab/R&D leasing activity in the nation’s 13 largest markets increased to 2.9 million square feet in Q3 2024 from 2 million square feet in in Q3 2023.

Other major markets present similar pictures, with leasing activity dominated by renewals. In San Diego, the market saw a striking 88% increase in gross leasing year-over-year in 2024, totaling 2 ...

Two-thirds – 67% – of life sciences companies surveyed had not set a Net Zero target in 2022. This is demonstrative of an increasingly serious sustainability challenge. But there is also ...

Life science investment sales across the U.S. ticked up by the end of last year to $7.2 billion, a jump of 33 percent year-over-year, as did the sheer number of deals, with 32 percent more closing ...